about
Genetic susceptibility and pulmonary fibrosisToxic elements in tobacco and in cigarette smoke: inflammation and sensitizationGlobal methylation patterns in idiopathic pulmonary fibrosisSafety of prolonged, repeated administration of a pulmonary formulation of tissue plasminogen activator in miceEthnic and racial differences in the presence of idiopathic pulmonary fibrosis at deathPulmonary fibrosis inducer, bleomycin, causes redox-sensitive activation of phospholipase D and cytotoxicity through formation of bioactive lipid signal mediator, phosphatidic acid, in lung microvascular endothelial cells.Matrix Remodeling in Pulmonary Fibrosis and Emphysema.Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N'-bis-2-Genetic susceptibility to interstitial pulmonary fibrosis in mice induced by vanadium pentoxide (V2O5).Determinants of initiation and progression of idiopathic pulmonary fibrosis.The Role of Aging in Idiopathic Pulmonary Fibrosis.Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.Occupational Exposures and Subclinical Interstitial Lung Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Air- Lung Study.Themes in fibrosis and gastrointestinal inflammation.Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration.Human lung injury following exposure to humic substances and humic-like substances.Metal load assessment in patient pulmonary lavages: towards a comprehensive mineralogical analysis including the nano-sized fraction.Idiopathic pulmonary fibrosis: pathogenesis and management.
P2860
Q28243802-011DA97E-FC45-46D9-88D5-35F2E1478AD4Q28386192-A5F61FDE-9939-4351-A6FB-313770D8BD1BQ28730666-CC0968EC-E1C5-4576-B78E-A83CB0B2B204Q33653355-BCCE4FE6-DB8C-4C14-A1F8-A815852599F7Q35803056-57C84606-3EF3-495E-9D9F-DEB21A99CB56Q36414620-EDDD58A7-03BF-48B1-838E-6EE2F635E445Q37088316-FDE2D82A-5ABE-4849-9F4D-5AC85C0AA103Q37557245-18DCF83A-5D23-44F7-AC4A-F434C643DA74Q37593998-5DB11A97-6A99-4EF7-86CD-ED88A16C371EQ37594222-D2CFD923-5E7F-414A-94BE-64A1C486FE34Q38436607-EC38CCB2-BB47-435E-BC48-B7865D2BFD1DQ38821078-CA867F59-079D-4C4C-AACE-40ED307A97C6Q40104303-138F32BB-196F-42D8-8F89-9C02DDC3343CQ42733498-719D64D2-85E5-4EE0-A000-597E5335E872Q47141962-44B9FEF8-FAAF-4B4C-8D1E-246D1737FA20Q47814234-A3EB0E3F-913D-448F-ADB3-D2CE82A316E7Q49666804-3CDC82B0-C513-41FA-B60B-FD13840AC561Q50326794-8C188E6E-FA13-40FF-BFC6-198AE72C9382
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Exposures and idiopathic lung disease.
@en
Exposures and idiopathic lung disease.
@nl
type
label
Exposures and idiopathic lung disease.
@en
Exposures and idiopathic lung disease.
@nl
prefLabel
Exposures and idiopathic lung disease.
@en
Exposures and idiopathic lung disease.
@nl
P356
P1476
Exposures and idiopathic lung disease.
@en
P2093
David Coultas
Varsha Taskar
P304
P356
10.1055/S-0028-1101277
P577
2008-12-01T00:00:00Z